Kavvabic Inc.

What Kavvabic Inc. does

Kavvabic Inc. is a privately held Canadian corporation founded in 2020 and headquartered in Toronto, focused on hemp- and cannabis-based biotechnology spanning wellness, food processing, fibres, and sustainable materials. The company holds a Health Canada hemp license authorizing culturing, importing, exporting, buying and selling to other cannabis/hemp license holders, and processing the plant, with THC molecule license applications underway. Product scope as listed on the company website includes cannabis (THC), hemp (CBD), extraction services, an AI-based molecular and cellular database service, pharmaceutical/bridge medications for addiction relief, construction products, textiles and fabrics, food and food processing, and farming methods. Technology positioning rests on proprietary AI-based molecular and cellular methods attributed to its affiliated parent, Global Financial Ecosystems (GFE).

The operating model is a diversified multi-vertical platform where monetization is intended to occur through a mix of licensing and royalties, B2B trading with other Health Canada license holders, direct sales of extraction and processed products, professional services for farming methods, and future pharma partnerships with selected pharmaceutical corporations. Pricing is custom per transaction, with funds held in purchaser trust and verified by company lawyers. Go-to-market is described as sales-led, with direct founder-led outreach to investors, planned public listing for retail investor access, and stated intent to position Kavvabic as a vehicle for the 'globalization of the kavvabic industry.'

Operating posture is early stage: the company explicitly maintains a small team and minimal overhead, lists only an international position as actively open, discloses no revenue, has no funding rounds on record, and relies on a single named executive (Gilles Kelly, Founder and Managing Director) as primary point of contact across investor, customer, and recruitment channels.

Name

Kavvabic Inc.

Legal name

Kavvabic Inc.

Website

https://kavvabic.ca

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Kavvabic Inc. is a Toronto-based private cannabis and hemp biotechnology company holding a Health Canada hemp license, building AI-based molecular methods and diversified products across CBD/THC, extraction, pharma, textiles, construction, and food, targeting licensed operators, industrial manufacturers, and pharma partners ahead of a planned public listing.

Ownership category

akta.pro rank

Product category

Cannabis & Hemp Biotechnology

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

CBD/Hemp Wellness & Supplements Retail (CRANAHAC)

akta.pro secondary industries

Industrial Hemp Farming (Fiber-Grade) (AFAGAFAC), Hemp & CBD Product Wholesale Distribution (CRAOAIAG), CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)

Keywords

• Hemp biotechnology
• Cannabis processing
• AI molecular methods
• Hemp fibre textiles
• Pharmaceutical extraction

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hemp License Operations: Culturing, importing and exporting, buying and selling to other cannabis and hemp license holders, and processing the plant under Health Canada hemp license.
2. THC License Revenue Streams: THC molecule licenses and related revenue streams planned as corporation progresses; all applicable licenses have been started.
3. Construction Products: New and different construction products from the kavvabic plant.
4. Textiles and Fabrics: Fibre processing to make textiles for clothing using advanced methods.
5. Extractions: Extraction products from the kavvabic plant.
6. Food and Food Processing: New food and food processing methods from the plant.
7. Farming and Farming Methods: New and different farming methods for the kavvabic plant.
8. Pharma and Molecules: Bridge medications during transition into globalization; working with selected pharmaceutical corporations on medications offering relief to addictions with little to no harm during detox.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Kavvabic Inc. develops hemp and cannabis-based biotechnology for wellness, food processing, fibres, and sustainable materials under Health Canada licensing. The company leverages AI-based molecular and cellular methods (developed through its affiliate Global Financial Ecosystems) to utilize every part of the hemp/cannabis plant, producing THC products, CBD hemp products, extraction services, construction materials, textiles, food products, and pharmaceutical bridge medications.

Product overview

Kavvabic Inc. is a cannabis and hemp company positioned for international globalization of the industry. The company operates as a diversified platform offering multiple product categories including Cannabis (THC), Hemp (CBD), and extraction services, alongside AI-based molecular database services for research purposes. Additional revenue streams include construction products, textiles/fabrics, food processing, and farming methods—all developed using proprietary methods distinct from existing industry practices. The company is AI-based and affiliated with Global Financial Ecosystems (GFE), leveraging molecular analysis capabilities for product development across pharmaceutical applications, textiles, and food products derived from the plant.

Differentiator

Problem solved

Functional benefit

Products and services

• Cannabis (THC) THC-based cannabis products and related offerings developed by Kavvabic Inc. for the cannabis industry, intended for licensed operators and downstream commercial buyers.
• Hemp (CBD) Hemp-derived CBD products containing little to no THC molecules, produced under Kavvabic's Health Canada hemp license for use by licensed buyers and industrial buyers.
• Extraction Services Extraction methods and processing services for cannabis and hemp plant materials, offered to license holders and industrial buyers under Kavvabic's licensed operations.
• Pharma and Molecules Pharmaceutical products and bridge medications derived from the Kavvabic plant, including formulations aimed at providing relief from addictions with little to no harm during detox, intended for selected pharmaceutical corporations.
• Molecular Database AI-based molecular and cellular database methods for molecular analysis, available exclusively to Kavvabic, selected affiliates, and subsidiaries of Global Financial Ecosystems.
• Construction Products Construction products derived from the Kavvabic plant using novel methods distinct from existing industry practices, intended for industrial and construction buyers.
• Textiles and Fabrics Textile products made from processed plant fibres for clothing applications, utilizing advanced molecular extraction methods claimed to be 'light years ahead' of current industry practice.
• Food and Food Processing Food products and processing methods utilizing the Kavvabic plant, intended for food industry buyers and downstream consumer product companies.
• Farming and Farming Methods Agricultural farming services and proprietary methods for cultivating the Kavvabic plant, offered to cultivators and agricultural operators.
• Database Inventory Database services for inventory management of Kavvabic plant-related products; transaction-based with funds held in purchaser's trust and verified by Kavvabic lawyers, with 50%-100% of cost paid or held in trust.

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Global Financial Ecosystems (GFE)coreStrategic or Co-development PartnerGFE is described as the parent corporation and the only AI and human biotech corporation. Kavvabic is positioned as an official/unofficial affiliate to GFE, which is 'the corporation put into place during the transition into globalization.' Kavvabic is the only company that will hold licenses held by GFE from its parent corporation and individual Gilles Kelly. GFE has global licenses for privacy protocol and access to technology 'not seen in this era on this planet.'

Scale indicators3 records

Recent moves7 records

Expansion highlights2 records

Direct peers

• Ecofibre: Australian hemp food, fibre, and CBD company operating across the full hemp value chain. Highly comparable to Kavvabic's multi-vertical hemp utilization (fibre, food, extraction, CBD).
• Charlotte's Web Holdings: Vertically integrated hemp-derived CBD wellness company selling tinctures, topicals, and pet products. Directly comparable to Kavvabic's CBD/hemp specialty retail and wellness product positioning.
• CV Sciences: US CBD specialty company with retail and wholesale hemp-derived CBD products. Comparable to Kavvabic's CBD specialty store and wholesale distribution model.
• Elixinol Wellness: Global hemp-derived CBD wellness brand with operations in multiple countries. Comparable to Kavvabic's CBD specialty and international expansion plans.
• cbdMD: US-based CBD wellness and supplements brand with broad product portfolio. Comparable to Kavvabic's CBD specialty retail and wellness positioning.
• HempFlax: European industrial hemp processor focused on fibre, shivs, and CBD extraction. Directly comparable to Kavvabic's advanced fibre processing and industrial hemp applications.

Broad incumbents

• Canopy Growth Corporation: Large Canadian licensed cannabis producer with diversified medical, recreational, and hemp product lines. Comparable as a broad Canadian cannabis/hemp incumbent with regulatory licensing.
• Cronos Group: Canadian licensed cannabis producer with international footprint. Comparable as a broad cannabis incumbent with hemp/cannabis licensing, R&D, and pharma partnerships.
• Aurora Cannabis: Canadian licensed producer with medical and consumer cannabis, plus hemp-derived CBD. Comparable as a Health Canada-licensed cannabis/hemp operator with full vertical integration.
• Tilray Brands: Major global cannabis and hemp company with operations across cultivation, processing, distribution, and pharma. Broadly comparable to Kavvabic's multi-vertical platform ambition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kavvabic Inc.